PP
RMD icon

PDT Partners’s ResMed RMD Stock Holding History

PDT Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,468
Closed -$2.44M – 706
2025
Q2 		$2.44M Sell
9,468
-2,367
-20% -$565K 0.14% 262
2025
Q1 		$2.65M Buy
11,835
+300
+3% +$70K 0.19% 185
2024
Q4 		$2.64M Hold
11,535
– – 0.23% 148
2024
Q3 		$2.82M Buy
+11,535
New +$2.58M 0.25% 130
2020
Q4 		– Sell
-38,100
Closed -$6.53M – 835
2020
Q3 		$6.53M Sell
38,100
-9,709
-20% -$1.79M 0.43% 79
2020
Q2 		$9.18M Sell
47,809
-16,209
-25% -$2.65M 0.62% 11
2020
Q1 		$9.43M Buy
64,018
+8
+0% +$1.27K 0.75% 15
2019
Q4 		$9.92M Sell
64,010
-10,295
-14% -$1.48M 0.61% 35
2019
Q3 		$10M Sell
74,305
-5,095
-6% -$668K 0.6% 33
2019
Q2 		$9.69M Hold
79,400
– – 0.57% 52
2019
Q1 		$8.26M Sell
79,400
-35
-0% -$3.61K 0.47% 84
2018
Q4 		$9.04M Buy
79,435
+12
+0% +$1.29K 0.51% 54
2018
Q3 		$9.16M Buy
+79,423
New +$8.7M 0.38% 88
2017
Q1 		– Sell
-38,200
Closed -$2.37M – 524
2016
Q4 		$2.37M Sell
38,200
-81,200
-68% -$4.97M 0.16% 224
2016
Q3 		$7.74M Hold
119,400
– – 0.45% 92
2016
Q2 		$7.55M Buy
119,400
+18,100
+18% +$1.07M 0.6% 16
2016
Q1 		$5.86M Buy
101,300
+24,044
+31% +$1.36M 0.37% 67
2015
Q4 		$4.15M Buy
77,256
+37,690
+95% +$2.12M 0.57% 30
2015
Q3 		$2.02M Buy
39,566
+3,713
+10% +$200K 0.05% 448
2015
Q2 		$2.02M Buy
35,853
+14,553
+68% +$919K 0.05% 423
2015
Q1 		$1.53M Buy
+21,300
New +$1.38M 0.04% 555
2014
Q2 		– Sell
-9,338
Closed -$417K – 1587
2014
Q1 		$417K Buy
+9,338
New +$419K 0.01% 1028
2013
Q3 		– Sell
-56,658
Closed -$2.56M – 1679
2013
Q2 		$2.56M Buy
+56,658
New +$2.69M 0.06% 436

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

PDT Partners's RMD Position: Q3 2025 in Review

PDT Partners sold out of ResMed (RMD) in Q3 2025, closing a stake of 9,468 shares — an estimated $2.44M sold.

PDT Partners first reported a position in RMD in Q2 2013 and held it in 23 quarters. The position peaked at $10M in Q3 2019. 950 funds tracked by Wall St. Rank hold RMD as of Q3 2025.

  • PDT Partners reported no remaining ResMed position as of Q3 2025 after selling out during the quarter.
  • PDT Partners sold 9,468 ResMed shares in Q3 2025, an estimated $2.44M.
  • PDT Partners first reported a position in ResMed in Q2 2013 and held it in 23 quarters.
  • PDT Partners's ResMed position peaked at $10M in Q3 2019.
  • 950 funds tracked by Wall St. Rank held ResMed as of Q3 2025.

Based on PDT Partners's 13F filing for Q3 2025, filed 17 Nov 2025.